免疫调节的细胞外囊泡:自身免疫性疾病治疗的新前沿
Hassan Shah1, Zhengkun Liu1, Weisheng Guo1
1Department of Minimally Invasive Interventional Radiology, The Second Affiliated Hospital, School of Biomedical Engineering, Guangzhou Medical University, Guangzhou 510260, China.
Essays in biochemistry
|May 14, 2025
概括
来自免疫细胞的细胞外囊泡 (EVs) 通过调节免疫反应,为治疗自身免疫性疾病提供了一个有前途的新策略. 这些来自细胞的EVs提供了针对性的免疫调节,比传统疗法风险更小.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 治疗方法 治疗方法
背景情况:
- 自身免疫性疾病源于免疫系统的失调,导致严重的健康问题.
- 目前的免疫抑制剂提供了缓解,但有严重的副作用,需要更安全的替代品.
- 来自免疫调节细胞的细胞外囊泡 (EV) 显示出有针对性的免疫调节的潜力.
研究的目的:
- 审查使用免疫调节细胞衍生的EVs用于自身免疫性疾病治疗的最新进展.
- 探索这些EV在免疫微环境中的作用机制.
- 讨论基于EV的自身免疫疗法的挑战和未来方向.
主要方法:
- 关于免疫调节细胞衍生的EVs的当前研究的文献综述.
- 对调节免疫反应的EV机制的分析.
- 综合了关于治疗应用和未来前景的发现.
主要成果:
- 免疫调节细胞衍生的EVs表现出从母细胞遗传的免疫抑制性质.
- 电动体促进免疫平衡,并减轻与基于细胞的疗法相关的风险.
- 最近的研究强调了EVs作为针对性自身免疫疾病治疗的有希望的候选人.
结论:
- 细胞外囊泡代表了对自身免疫性疾病的新治疗途径.
- 对EV机制和临床翻译的进一步研究对于开发有效的治疗方法至关重要.
- 基于EV的疗法为免疫调节提供了潜在的更安全,更有针对性的方法.
更多相关视频
08:02In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
2.5K
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
565
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Cell-surface Signaling
51.3K
Hormones—or any molecule that binds to a receptor, known as a ligand—that are lipid-insoluble (water-soluble) are not able to diffuse across the cell membrane. In order to be able to affect a cell without entering it, these hormones bind to receptors on the cell membrane. When a first messenger, a hormone, binds to a receptor, a signal cascade is set off, causing second messengers, proteins inside the cell, to become activated, resulting in downstream effects.
51.3K
Tumor Immunotherapy
406
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
406
